MARC details
| 000 -LEADER |
|---|
| fixed length control field |
01449nam a22003617a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20220328110345.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
220328b |||||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780826129345 (hbk.) |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
krea |
| 043 ## - GEOGRAPHIC AREA CODE |
|---|
| Geographic area code |
n-us--- |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.89122 BRE |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Breggin, Peter Roger, |
| Dates associated with a name |
1936- |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Brain disabling treatments in psychiatry: drugs, electroshock, and the psychopharmaceutical complex / |
| Statement of responsibility, etc. |
Peter R. Breggin. |
| 246 ## - VARYING FORM OF TITLE |
|---|
| Title proper/short title |
Brain-Disabling Treatments in Psychiatry: Drugs, Electroshock, and the Psychopharmaceutical Complex |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
2nd ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
New York |
| Name of publisher, distributor, etc. |
Springer Publishing Company |
| Date of publication, distribution, etc. |
2008 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xxx, 546 p. ; |
| Dimensions |
24 cm. |
| 500 ## - GENERAL NOTE |
|---|
| General note |
MSR B863/08<br/>$87.95/- |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references (p. 463-526) and index. |
| 610 10 - SUBJECT ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
United States. |
| Subordinate unit |
Food and Drug Administration. |
| 610 12 - SUBJECT ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
United States. |
| Subordinate unit |
Food and Drug Administration. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Psychotropic drugs |
| General subdivision |
Side effects. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Brain |
| General subdivision |
Effect of drugs on. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Electroconvulsive therapy |
| General subdivision |
Complications. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Iatrogenic diseases. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Mental Disorders |
| General subdivision |
therapy |
| Geographic subdivision |
United States. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Brain Damage, Chronic |
| General subdivision |
etiology |
| Geographic subdivision |
United States. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Drug Industry |
| Geographic subdivision |
United States. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Electroconvulsive Therapy |
| General subdivision |
adverse effects |
| Geographic subdivision |
United States. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Psychotropic Drugs |
| General subdivision |
adverse effects |
| Geographic subdivision |
United States. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Books |
